Dissemin is shutting down on January 1st, 2025

Published in

Royal Society of Chemistry, RSC Medicinal Chemistry, 3(13), p. 258-279, 2022

DOI: 10.1039/d1md00394a

Links

Tools

Export citation

Search in Google Scholar

Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics

Journal article published in 2022 by Hari Madhav ORCID, Ehtesham Jameel ORCID, Mohammad Rehan ORCID, Nasimul Hoda ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Chromones were proved as an important anti-neurodegenerative and neurogenesis agent. They act in numerous ways such as an efficient inhibitory activity against AChE, BuChE, MOA, Aβ aggregation, and neuroprotection activities.